Expleo Solutions Limited (EXPLEOSOL.NS)
- Previous Close
1,321.60 - Open
1,321.60 - Bid --
- Ask --
- Day's Range
1,305.00 - 1,345.60 - 52 Week Range
1,198.20 - 1,777.20 - Volume
13,660 - Avg. Volume
29,464 - Market Cap (intraday)
20.292B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
19.55 - EPS (TTM)
66.87 - Earnings Date May 23, 2024 - May 27, 2024
- Forward Dividend & Yield 5.00 (0.38%)
- Ex-Dividend Date Jul 14, 2023
- 1y Target Est
--
Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide. It offers computer programming, consultancy and related activities, quality management, software development, software testing, software development, digital transformation, product and process engineering, quality and testing, and customer support and maintenance services. The company was formerly known as SQS India BFSI Limited and changed its name to Expleo Solutions Limited in April 2019. Expleo Solutions Limited was incorporated in 1998 and is based in Chennai, India. Expleo Solutions Limited Limited is a subsidiary of Expleo Technology Germany GmbH.
investors.expleo.comRelated News
Performance Overview: EXPLEOSOL.NS
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EXPLEOSOL.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EXPLEOSOL.NS
Valuation Measures
Market Cap
20.50B
Enterprise Value
19.15B
Trailing P/E
19.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.18
Price/Book (mrq)
3.65
Enterprise Value/Revenue
2.04
Enterprise Value/EBITDA
11.48
Financial Highlights
Profitability and Income Statement
Profit Margin
11.04%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
9.41B
Net Income Avi to Common (ttm)
1.04B
Diluted EPS (ttm)
66.87
Balance Sheet and Cash Flow
Total Cash (mrq)
1.29B
Total Debt/Equity (mrq)
4.37%
Levered Free Cash Flow (ttm)
--
Research Analysis: EXPLEOSOL.NS
Company Insights: EXPLEOSOL.NS
EXPLEOSOL.NS does not have Company Insights